The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities and Cleansing Notice

22 Mar 2022 07:00

RNS Number : 5742F
Oilex Ltd
22 March 2022
 

ASX - RNS Announcement

22 March 2022

 

ASX: OEX

AIM: OEX

 

 

ISSUE OF SECURITIES AND CLEANSING NOTICE

 

(Oilex or the Company) wishes to advise that following shareholder approval received at the 17 February 2022 Shareholder Meeting, it has issued the following securities:

 

· 711,295,152 unquoted options (Placement Options). The Placement Options are exercisable at GBP 0.28 pence (0.518 AUD cents) per share on or before 31 December 2022. The Options were issued to shareholders as a one free attaching unquoted option for every two Placement Shares subscribed for, in the January 2022 placement,

 

· 54,839,185 unquoted options, exercisable at GBP 0.14 pence (0.259 AUD cents) on or before 31 December 2023 (Fee Options), to Novum Securities.

 

Exercise of Options

Novum has now exercised the 54,839,185 unquoted Fee Options into fully paid ordinary shares.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of 54,839,185 Shares to trade on AIM (Admission). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 24 March 2022. Following Admission, the Company will have 7,167,790,704 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 7,167,790,704.

 

Section 708A(5)(e) Statement

 

The Corporations Act (Cth) (Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.

 

Pursuant to the issue of the 54,839,185 Ordinary Shares on 17 March 2022, Oilex gives notice under section 708A(5)(e) of the Act that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information:

(i) That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

(ii) That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

A. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

B. The rights and liabilities attaching to the Shares.

 

The relevant Appendix 2A is lodged via ASX on-line forms.

 

For and on behalf of Oilex Ltd

Suzie Foreman

Company Secretary

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Roland Wessel

Chief Executive Officer

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJTMFTMTJTMFT
Date   Source Headline
14th May 20217:00 amRNSIssue of Securities and Appendix 2A
7th May 20217:00 amRNSNotice of General Meeting
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20219:55 amRNSChange of Interests of Substantial Holder
30th Apr 20217:36 amRNSMarch 2021 Quarterly Report
29th Apr 202111:06 amRNSIssue of Securities
23rd Apr 202110:24 amRNSIssue of Securities
23rd Apr 20217:00 amRNSInd Govt approval of Cambay PSC Work Prog/Budget
21st Apr 20211:43 pmRNSAcquisition Funding Arranged
13th Apr 20217:00 amRNSBhandut PSC PI Sale Finalisation
7th Apr 20215:51 pmRNSIssue of Securities
6th Apr 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20219:32 amRNSUpdate Regarding Cambay Settlement
17th Mar 20217:00 amRNSAppendix 2A
16th Mar 20217:00 amRNSCorrection: Equity Issue
15th Mar 20217:19 amRNSHalf Year Accounts
15th Mar 20217:00 amRNSSeries D Loan Restructure and Equity Issue
17th Feb 20217:00 amRNSAppendix 3Y P Schwarz
17th Feb 20217:00 amRNSAppendix 3Y P Haywood
15th Feb 20217:59 amRNSUpdate on proposal to acq interest in Cambay PSC
15th Feb 20217:46 amRNSTrading Halt Request
12th Feb 20218:15 amRNSIssue of Securities and Appendix 2A
1st Feb 20217:00 amRNSDecember 2020 Quarterly Report
24th Dec 20207:00 amRNSSeries C Loan Extension
17th Dec 202011:20 amRNSExecutive Directors Contract Extensions
17th Dec 202010:51 amRNSIssue of Securities
16th Dec 20207:00 amRNSResults of Annual General Meeting
14th Dec 20207:00 amRNSCompletion of East Irish Sea Transaction P2446
16th Nov 20207:00 amRNS2020 Notice of Annual General Meeting
6th Nov 20207:55 amRNSCorrection Waiver Granted
5th Nov 20207:30 amRNSWaiver Granted
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Financial Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Directors Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Business Review
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Announcement
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Chairmans Review
30th Oct 20209:54 amRNSSeptember 2020 Quarterly Report
30th Oct 20209:37 amRNSSeries C Loan Restructure
15th Oct 20208:54 amRNSArmour Completion and Update on Projects
1st Oct 20207:08 amRNSAppendix 4G
1st Oct 20207:00 amRNSCorporate Governance Statement 2020
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Financial Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Directors Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Business Review
1st Oct 20207:00 amRNSUnaudited Annual Report 2020 - Announcement
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report -Chairmans Review
14th Sep 202012:17 pmRNSArmour Share Purchase Agreement – Update
10th Aug 20207:00 amRNSIssue of Securities and Appendix 2A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.